03:42 PM EDT, 05/02/2024 (MT Newswires) -- Burlington Stores ( BURL ) is likely to generate better sales growth than previously expected while its earnings growth outlook has improved amid increased conviction that the off-price retailer and its peers will continue to gain market share from department stores, UBS Securities said Thursday. The brokerage upgraded its rating on the Burlington...

On Thursday, Regeneron Pharmaceuticals Inc reported first-quarter adjusted EPS of $9.55, down 5% Y/Y, missing the consensus of $10.10. The company reported sales of $3.15 billion, missing the consensus of $3.22 billion. First quarter 2024 revenues decreased by 1%; excluding Ronapreve (COVID-19 antibody), revenues increased by 7%. Eylea US sales fell 16% to $1.2 billion, primarily due to changing market dynamics, resulting in lower volumes and...

03:39 PM EDT, 05/02/2024 (MT Newswires) -- (Updates with further details, companies declining or not responding to request for comment in second to fourth paragraphs) Nomura Holdings ( NMR ) and Mizuho Financial Group ( MFG ) are facing over $100 million in potential losses tied to several failed stock trades by investment fund All Blue Capital, Bloomberg reported, citing...

03:42 PM EDT, 05/02/2024 (MT Newswires) -- Sarepta Therapeutics' ( SRPT ) regulatory review of its Elevidys therapy for Duchenne muscular dystrophy is advancing faster than anticipated, Morgan Stanley said in a report emailed Thursday. Overall, we view acceleration of the [US Food and Drug Administration] review process into labeling discussions ahead of schedule as a positive, Morgan Stanley said....